Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 2/20 | 0.33 |
| ▸ | HTR6 | P50406 | 2/20 | 0.33 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL329494 | 0.75 | LMNA (0.32) | P2RX4 | |
| SCHEMBL3453648 | 0.75 | LMNA (0.36) | P2RX4 | |
| SCHEMBL31132386 | 0.73 | TTR (0.31) | — | |
| SCHEMBL11129882 | 0.69 | P2RX4 (0.40) | P2RX4 | |
| SCHEMBL6248730 | 0.69 | P2RX4 (0.35) | P2RX4 | |
| SCHEMBL29434173 | 0.66 | P2RX4 (0.37) | HRH1HTR6P2RX4 | |
| SCHEMBL1198914 | 0.66 | P2RX4 (0.37) | HRH1HTR6P2RX4 | |
| SCHEMBL30292820 | 0.66 | SIGMAR1 (0.38) | P2RX4 | |
| SCHEMBL21815682 | 0.66 | SIGMAR1 (0.38) | P2RX4 | |
| SCHEMBL19041276 | 0.66 | ALDH1A1 (0.45) | HRH1HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2066150-B1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC (KR) | 2010-05-26 | — | — | EP | disclosed |
| EP-1107063-B1 | Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates | DU PONT (US) | 2010-03-10 | — | — | EP | disclosed |
| US-20090184631-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-23 | — | — | US | disclosed |
| US-20090174316-A1 | Novel red electroluminescent compounds and organi electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-09 | — | — | US | disclosed |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| EP-2066150-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-06-03 | — | — | EP | disclosed |
| EP-2055710-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-06 | — | — | EP | disclosed |
| EP-2055709-A2 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-06 | — | — | EP | disclosed |
| US-6864039-B2 | Such as naphthylvinyl-pyridine; for improved heat stability and image resolution | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-03-08 | — | — | US | disclosed |
| US-20030219681-A1 | Photobleachable compounds for use in flexographic printing plates | CHENG LAP KIN (US) | 2003-11-27 | — | — | US | disclosed |
| EP-1107063-A1 | Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090184631-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | ALDH1A2, ODC1, NDUFS2 | MAOB 1141/4885HRH1 3677/4885HTR6 4583/4885 |
| US-20090174316-A1 | Novel red electroluminescent compounds and organi electroluminescent device using the same | ALPI, IK, ALDH1A2 | MAOB 4281/4885HRH1 3653/4885HTR6 4810/4885 |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | MAOB 1216/4885HRH1 3729/4885HTR6 4606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.